Puck T. Pelzer

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial design.

The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial design.

Journal: Vaccine

Published: March 18, 2026

Prioritizing countries for TB vaccine readiness research using a global stakeholder-centric approach.

Prioritizing countries for TB vaccine readiness research using a global stakeholder-centric approach.

Journal: PLOS global public health

Published: April 29, 2025

Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants.

Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants.

Journal: Vaccine

Published: February 25, 2025

Vaccine confidence and potential implications for new tuberculosis vaccines.

Vaccine confidence and potential implications for new tuberculosis vaccines.

Journal: BMC global and public health

Published: January 06, 2025

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials.

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials.

Journal: The Lancet. Respiratory medicine

Published: November 06, 2024

Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review.

Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review.

Journal: Expert review of vaccines

Published: July 05, 2024

Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data.

Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data.

Journal: The Lancet. Microbe

Published: May 17, 2024

Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review.

Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review.

Journal: PLOS global public health

Published: January 23, 2024

The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa.

The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa.

Journal: PloS one

Published: October 02, 2023

Does BCG vaccination protect against infection with M. tuberculosis?

Does BCG vaccination protect against infection with M. tuberculosis?

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: June 02, 2022

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.

Journal: NPJ vaccines

Published: May 31, 2022

Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines.

Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines.

Journal: PLOS global public health

Published: September 27, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026